State Laws Allow HMO Members To Sue

2 December 1997

New state laws in Texas and Missouri allow health maintenanceorganization members to sue their plans over perceived restrictions on access to needed care.

Until now, consumers have been unable to take action against managed care providers by the 1974 Employee Retirement Income Security Act, which says that all denial-of-care lawsuits must be heard in federal rather than state courts and limited the size of awards, and by the Corporate Practice of Medicine Doctrine, which says that as HMOs do not practice medicine, they cannot be liable for malpractice lawsuits of any kind. Missouri and Texas legislators circumvented both those rulings, allowing state HMO members to sue their plan should they feel threatened or harmed by the withholding of what they perceive to be "necessary care."

Similar legislation is pending in 17 other states, while in Congress, Republicans Senator Alfonse D'Amato and Representative Charles Norwood have proposed federal amendments to ERISA which would do away with existing federal court monopolies on consumer-HMO lawsuits.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight